{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:05:33Z","timestamp":1794956733252,"version":"4.9.1"},"reference-count":30,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gestational trophoblastic disease (\n                    <jats:styled-content style=\"fixed-case\">GTD<\/jats:styled-content>\n                    ) arises from abnormal placenta and is composed of a spectrum of premalignant to malignant disorders. Changes in epidemiology of\n                    <jats:styled-content style=\"fixed-case\">GTD<\/jats:styled-content>\n                    have been noted in various countries. In addition to histology, molecular genetic studies can help in the diagnostic pathway. Earlier detection of molar pregnancy by ultrasound has resulted in changes in clinical presentation and decreased morbidity from uterine evacuation. Follow\u2010up with human chorionic gonadotropin (\n                    <jats:styled-content style=\"fixed-case\">hCG<\/jats:styled-content>\n                    ) is essential for early diagnosis of gestational trophoblastic neoplasia (\n                    <jats:styled-content style=\"fixed-case\">GTN<\/jats:styled-content>\n                    ). The duration of\n                    <jats:styled-content style=\"fixed-case\">hCG<\/jats:styled-content>\n                    monitoring varies depending on histology type and regression rate. Low\u2010risk\n                    <jats:styled-content style=\"fixed-case\">GTN<\/jats:styled-content>\n                    (\n                    <jats:styled-content style=\"fixed-case\">FIGO<\/jats:styled-content>\n                    Stages I\u2013\n                    <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>\n                    : score &lt;7) is treated with single\u2010agent chemotherapy but may require additional agents; although scores 5\u20136 are associated with more drug resistance, overall survival approaches 100%. High\u2010risk\n                    <jats:styled-content style=\"fixed-case\">GTN<\/jats:styled-content>\n                    (\n                    <jats:styled-content style=\"fixed-case\">FIGO<\/jats:styled-content>\n                    Stages\n                    <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\n                    \u2013\n                    <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>\n                    : score &gt;7 and Stage\n                    <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content>\n                    ) is treated with multiple agent chemotherapy, with or without adjuvant surgery for excision of resistant foci of disease or radiotherapy for brain metastases, achieving a survival rate of approximately 90%. Gentle induction chemotherapy helps reduce early deaths in patients with extensive tumor burden, but late mortality still occurs from recurrent resistant tumors.\n                  <\/jats:p>","DOI":"10.1002\/ijgo.12615","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T03:48:35Z","timestamp":1539229715000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":366,"title":["Update on the diagnosis and management of gestational trophoblastic disease"],"prefix":"10.1002","volume":"143","author":[{"given":"Hextan Y.S.","family":"Ngan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Queen Mary Hospital University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Seckl","sequence":"additional","affiliation":[{"name":"Departments of Histopathology and Medical Oncology Charing Cross Trophoblastic Disease Center Charing Cross Campus of Imperial College London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Division of Gynecologic Oncology Brigham and Women's Hospital Dana\u2010Farber Cancer Institute Harvard Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Golfier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology French Trophoblastic Disease Reference Centre Lyon University Hospital Claude Bernard Lyon 1 University Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paradan K.","family":"Sekharan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Institute of Maternal and Child Health Medical College Calicut India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lurain","sequence":"additional","affiliation":[{"name":"John I. Brewer Trophoblastic Disease Center Northwestern University Feinberg School of Medicine Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Massuger","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology Department of Obstetrics and Gynecology Radboud University Medical Centre Nijmegen Nijmegen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000128"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.073"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60280-2"},{"key":"e_1_2_10_5_1","volume-title":"Gestational Trophoblastic Disease","author":"Hancock BW","year":"2015"},{"key":"e_1_2_10_6_1","first-page":"595","article-title":"Familial recurrent hydatidiform mole: A review","volume":"49","author":"Fisher RA","year":"2004","journal-title":"J Reprod Med"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1740"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.t01-1-01037.x"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90342-9"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(03)90120-2"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.06.005"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(12)60026-5"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0900696"},{"issue":"9","key":"e_1_2_10_14_1","first-page":"CD007289","article-title":"Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia","author":"Wang Q","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.12.008"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.09.031"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.02388.x"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09085-2"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.01.021"},{"issue":"6","key":"e_1_2_10_20_1","first-page":"CD007102","article-title":"First\u2010line chemotherapy in low\u2010risk gestational trophoblastic neoplasia","author":"Lawrie TA","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001248"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.072"},{"issue":"1","key":"e_1_2_10_23_1","first-page":"CD008891","article-title":"Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia","author":"Alazzam M","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_24_1","first-page":"262","article-title":"Survival of women with gestational trophoblastic neoplasia and liver metastases: Is it improving?","volume":"57","author":"Ahamed E","year":"2012","journal-title":"J Reprod Med"},{"key":"e_1_2_10_25_1","first-page":"465","article-title":"Management of brain metastases in patients with high\u2010risk gestational trophoblastic tumors","volume":"47","author":"Newlands ES","year":"2002","journal-title":"J Reprod Med"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.09.083"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.1817"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32894-5"},{"key":"e_1_2_10_29_1","first-page":"288","article-title":"Brain metastasis in gestational trophoblastic neoplasia: An update","volume":"57","author":"Neubauer NL","year":"2012","journal-title":"J Reprod Med"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.05.006"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.10.024"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijgo.12615","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijgo.12615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T07:24:14Z","timestamp":1713338654000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/ijgo.12615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1002\/ijgo.12615"],"URL":"https:\/\/doi.org\/10.1002\/ijgo.12615","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-10-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}